Session Information
2007 Midyear Clinical Meeting
Significant Developments in the Medication Pipeline
Track: Educational Session
Program Code: 314-L01
Date: Thursday, December 6, 2007
Time: 9:00 a.m. - 12:00 p.m.
Location:
Bellini 2005/2006/2105/2106MEETING PLANNING ASSOCIATE:
Dr. Karla Miller, PharmD, BCPP, Director of Medication Usage and Safety, Hospital Corporation of America
MODERATOR:
Dr. Karla Miller, PharmD, BCPP, Director of Medication Usage and Safety, Hospital Corporation of America
PRESENTERS:
Dr. Karla Miller, PharmD, BCPP, Director of Medication Usage and Safety, Hospital Corporation of America
Dr. Shannon Drayton, PharmD, BCPP, Assistant Professor, South Carolina College of Pharmacy
Dr. Anne Zichterman, PharmD, BCPS, Pharmacy Clinical Specialist, Baptist Hospital
Dr. Patricia Ross, Pharm.D., Clinical Pharmacist, The Johns Hopkins Hospital
Dr. Melinda Neuhauser, PharmD, Clinical Pharmacy Specialist, Infectious Diseases, VA Pharmacy Benefits Management SHG
Dr. David Bearden, PharmD, Clinical Associate Professor, Oregon State University
LEARNING OBJECTIVES
- Describe novel medications that are currently in clinical trials.
- Analyze the mechanism of action of pipeline medications.
- Discuss the clinical implications of novel medications on disease state management.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 314-L01)
This session is a part of: